Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma
{{output}}
Glioblastoma (GBM) is the most aggressive and treatment-resistant primary brain tumor in adults. Conventional therapies offer limited benefit due to the tumor's heterogeneity, invasive nature, and the presence of the blood-brain barrier, which restricts thera... ...
